Saturday, Sep 26, 2020 | Last Update : 02:27 AM IST

185th Day Of Lockdown

Maharashtra128396397321434345 Andhra Pradesh6543855794745558 Tamil Nadu5636915082109076 Karnataka5485574446588331 Uttar Pradesh3742773076115366 Delhi2606232243755123 West Bengal2378692080424606 Odisha196888161044805 Telangana1816271501601080 Bihar174266159700878 Assam165582135141608 Kerala15445898720614 Gujarat1289491093113382 Rajasthan1227201023301352 Haryana118554984101177 Madhya Pradesh115361814752007 Punjab105220814752860 Chhatisgarh9562358833680 Jharkhand7643862945626 Jammu and Kashmir68614480791024 Uttarakhand4440432154501 Goa3055224347360 Puducherry2489519311467 Tripura2378616955245 Himachal Pradesh133869232125 Chandigarh109688342123 Manipur9537736959 Arunachal Pradesh8416607113 Nagaland5730459810 Meghalaya4733252838 Sikkim2447190529 Mizoram158510120
  Business   Companies  06 Aug 2020  Novavax announces COVID-19 vaccine supply deal with Serum Institute

Novavax announces COVID-19 vaccine supply deal with Serum Institute

REUTERS
Published : Aug 6, 2020, 10:16 am IST
Updated : Aug 6, 2020, 10:16 am IST

Novavax reported that its experimental vaccine produced high levels of antibodies against coronavirus in a small, early-stage clinical trial

 Novavax signs Covid-19 vaccine supply deal with India's Serum Institute. (AFP Photo)
  Novavax signs Covid-19 vaccine supply deal with India's Serum Institute. (AFP Photo)

Novavax Inc said on Wednesday it has entered a supply and license agreement with the Serum Institute of India for the development and commercialization of its COVID-19 vaccine candidate.

The Indian drugmaker will have exclusive rights for the vaccine in India during the term of the deal and non-exclusive rights during the “Pandemic Period” in all countries other than those designated by the World Bank as upper-middle or high-income countries.

 

The deal was signed on July 30, according to an SEC filing by Novavax.

On Tuesday, Novavax reported that its experimental COVID-19 vaccine produced high levels of antibodies against the novel coronavirus in a small, early-stage clinical trial, and that it could start a large pivotal Phase III trial as soon as late September.

Tags: covid-19, coronavirus, vaccine, novavax, serum institute